Versatile rapid diagnostic platform receives CE mark

AnteoTech has announced that its EuGeni Reader and accompanying COVID-19 Antigen Rapid Test (ART) have received CE mark registration as the company looks to progress with European distribution.

Show CommentsClose Comments

Leave a comment

%d